2017 White Paper on Recent Issues in Bioanalysis: Aren’t Bmv Guidance/Guidelines ‘Scientific’? (Part 1 – LCMS: Small Molecules, Peptides and Small Molecule Biomarkers)

References

• Savoie N , BoothBP, BradleyTet al. 2008 White Paper: the 2nd calibration and validation group workshop on recent issues in good laboratory practice bioanalysis. Bioanalysis1 (1), 19–30 (2009).
   PubMed Web of Science ®Google Scholar
• Savoie N , GarofoloF, van AmsterdamPet al. 2009 White Paper on recent issues in regulated Bioanalysis from the 3rd calibration and validation group workshop. Bioanalysis2 (1), 53–68 (2010).
   PubMed Web of Science ®Google Scholar
• Savoie N , GarofoloF, van AmsterdamPet al. 2010 White Paper on recent issues in regulated Bioanalysis and global harmonization of bioanalytical guidance. Bioanalysis2 (12), 1945–1960 (2010).
   PubMed Web of Science ®Google Scholar
• Garofolo F , RocciM, DumontIet al. 2011 White Paper on recent issues in Bioanalysis and regulatory findings from audits and inspections. Bioanalysis3 (18), 2081–2096 (2011).
   PubMed Web of Science ®Google Scholar
• DeSilva B , GarofoloF, RocciMet al. 2012 White Paper on recent issues in Bioanalysis and alignment of multiple guidelines. Bioanalysis4 (18), 2213–2226 (2012).
   PubMed Web of Science ®Google Scholar
• Stevenson L , RocciM, GarofoloFet al. 2013 White Paper on recent issues in bioanalysis: “Hybrid” - the best of LBA & LC/MS. Bioanalysis5 (23), 2903–2918 (2013).
   PubMed Web of Science ®Google Scholar
• Fluhler E , HayesR, GarofoloFet al. 2014 White Paper on recent issues in bioanalysis: a full immersion in Bioanalysis (Part 1 – small molecules by LCMS). Bioanalysis6 (22), 3039–3049 (2014).
   PubMed Web of Science ®Google Scholar
• Dufield D , NeubertH, GarofoloFet al. 2014 White Paper on recent issues in bioanalysis: a full immersion in Bioanalysis (Part 2 – hybrid LBA/LCMS, ELN & regulatory agencies’ input). Bioanalysis6 (23), 3237–3249 (2014).
   PubMed Web of Science ®Google Scholar
• Stevenson L , AmaravadiL, MylerHet al. 2014 White Paper on recent issues in bioanalysis: a full immersion in Bioanalysis (Part 3 – LBA and immunogenicity). Bioanalysis6 (24), 3355–3368 (2014).
   PubMed Web of Science ®Google Scholar
• Welink J , FluhlerE, HughesNet al. 2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 1 – small molecules by LCMS). Bioanalysis7 (22), 2913–2925 (2015).
   PubMed Web of Science ®Google Scholar
• Ackermann B , NeubertH, HughesNet al. 2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 2 – hybrid LBA/LCMS and input from regulatory agencies). Bioanalysis7 (23), 3019–3034 (2015).
   PubMed Web of Science ®Google Scholar
• Amaravadi L , SongA, MylerHet al. 2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3 – LBA, biomarkers and immunogenicity). Bioanalysis7 (24), 3107–3124 (2015).
   PubMed Web of Science ®Google Scholar
• Yang E , WelinkJ, CapeSet al. 2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1 – small molecules, peptides and small molecule biomarkers by LCMS). Bioanalysis8 (22), 2363–2378 (2016).
   PubMed Web of Science ®Google Scholar
• Song A , LeeA, GarofoloFet al. 2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 2 – Hybrid LBA/LCMS and input from regulatory agencies). Bioanalysis8 (23), 2457–2474 (2016).
   PubMed Web of Science ®Google Scholar
• Richards S , AmaravadiL, PillutlaRet al. 2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 – LBA, biomarkers and immunogenicity). Bioanalysis8 (23), 2475–2496 (2016).
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research, Center for Veterinary Medicine . Guidance for Industry, Bioanalytical Method Validation. Rockville, MD, USA (2001).
   Google Scholar
• European Medicines Agency . Committee for Medicinal Products for Human Use (CHMP). Guideline on Bioanalytical Method Validation. EMEA/CHMP/EWP/192217/2009. London, UK (2011).
   Google Scholar
• Japanese Ministry of Health, Labour and Welfare . Guideline on Bioanalytical Method Validation in Pharmaceutical Development. Japan (2013). www.nihs.go.jp/drug/BMV/250913_BMV-GL_E.pdf.
   Google Scholar
• US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Veterinary Medicine . Draft Guidance for Industry. Data Integrity and Compliance With CGMP. Rockville, MD, USA (2016). www.fda.gov/downloads/drugs/guidances/ucm495891.pdf.
   Google Scholar
• Li W , CohenLH. Quantitation of endogenous analytes in biofluid without a true blank matrix. Anal. Chem. 75 (21), 5854–5859 (2003).
   PubMed Web of Science ®Google Scholar
• Cox JM , ButlerJP, LutzkeBSet al. A validated LC–MS/MS method for neurotransmitter metabolite analysis in human cerebrospinal fluid using benzoyl chloride derivatization. Bioanalysis17 (9), 2461–2475 (2015).
   Google Scholar
• Jones BR , SchultzGA, EcksteinJA, AckermannBL. Surrogate matrix and surrogate analyte approaches for definitive quantitation of endogenous biomolecules. Bioanalysis4 (19), 2343–2356 (2012).
   PubMed Web of Science ®Google Scholar
• Diczfalusy U , KanebrattK, BredbergEet al. 4β-Hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after induction with rifampicin. Br. J. Clin. Pharmacol. 67 (1), 38–43 (2009).
   PubMed Web of Science ®Google Scholar
• Tomalik-Scharte D , LutjohannD, DoroshyenkoOet al. Plasma 4β-hydroxycholesterol: an endogenous CYP3A metric? Clin. Pharmacol. Ther . 86 (2), 147–153 (2009).
   PubMed Web of Science ®Google Scholar
• Leil TA , KasichayanulaS, BoultonDW, LaCretaF. Evaluation of 4β-Hydroxycholesterol as a clinical biomarker of CYP3A4 drug interactions using a Bayesian mechanism-based pharmacometric model. CPT Pharmacometrics Syst. Pharmacol. 3, 1–10 (2014).
   PubMedGoogle Scholar
• Di L . Strategic approaches to optimizing peptide ADME properties. AAPS J. 17 (1), 134–143 (2015).
   PubMed Web of Science ®Google Scholar
• Rago B , NegahbanA. Outsource-ability of HRMS-based DMPK assays. Bioanalysis8 (16), 1641–1644 (2016).
   PubMed Web of Science ®Google Scholar
• Spooner N , CapeS, SummerfieldS. Outsourcing strategies in bioanalysis. Bioanalysis9 (15), 1125–1126 (2017).
   Web of Science ®Google Scholar
• Ciccimaro E , RanasingheA, D’ArienzoCet al. Strategy to improve the quantitative LC-MS analysis of molecular ions resistant to gas-phase collision induced dissociation: application to disulfide-rich cyclic peptides. Anal. Chem. 86 (23), 11523–11527 (2014).
   PubMed Web of Science ®Google Scholar
• Fu Y , XiaYQ, FlarakosJet al. Differential mobility spectrometry coupled with multiple ion monitoring in regulated LC-MS/MS Bioanalysis of a therapeutic cyclic peptide in human plasma. Anal. Chem. 88 (7), 3655–3661 (2016).
   PubMed Web of Science ®Google Scholar
• Fung EN , JemalM, AubryAF. High-resolution MS in regulated bioanalysis: where are we now and where do we go from here?Bioanalysis5 (10), 1277–1284 (2013).
   PubMed Web of Science ®Google Scholar
• Iavarone AT , WilliamsER. Mechanism of charging and supercharging molecules in electrospray ionization. J. Am. Chem. Soc. 125 (8), 2319–2327 (2003).
   PubMed Web of Science ®Google Scholar
• Kay RG , HandsJT, HawthorneG. Validation of an ultrasensitive LC–MS/MS method for PTH 1–34 in porcine plasma to support a solid dose PK study. Bioanalysis7 (12), 1435–1445 (2015).
   PubMed Web of Science ®Google Scholar
• Iavarone AT , JurchenJC, WilliamsER. Supercharged protein and peptide ions formed by electrospray ionization. Anal. Chem. 73 (7), 1455–1460 (2001).
   PubMed Web of Science ®Google Scholar
• Halquist MS , SakagamiM, KarnesHT. Determination of oxyntomodulin, an anorectic polypeptide, in rat plasma using 2D-LC-MS/MS coupled with ion pair chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 15 (903), 102–111 (2012).
   Google Scholar
• Health Canada, Bureau of Pharmaceutical Sciences Therapeutic Products Directorate . Notice: Clarification of Bioanalytical Method Validation Procedures (2015).
   Google Scholar
• Health Canada, Bureau of Pharmaceutical Sciences Therapeutic Products Directorate . Addendum to Notice: Clarification of Bioanalytical Method Validation Procedures (2016).
   Google Scholar
• European Medicines Agency . Committee for Medicinal Products for Human Use (CHMP). Guideline on the Investigation of Bioequivalence. CPMP/EWP/QWP/1401/98 Rev. 1/Corr **. London, UK (2010). www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdf.
   Google Scholar
• Welink J . Determination of the two diastereoisomers of Lobaplatin (D-19466) in plasma ultrafiltrate of cancer patients with a normal or an impaired kidney or liver function by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. B675 (1), 107–111 (1996).
   PubMedGoogle Scholar
• Garcia-Arieta A , Abad-SantosF, Rodríguez-MartínezMAet al. An eutomer/distomer ratio near unity does not justify non-enantiospecific assay methods in bioequivalence studies. Chirality17 (8), 470–475 (2005).
   PubMed Web of Science ®Google Scholar
• Torrado JJ , BlancoM, FarréM, RosetP, García-ArietaA. Rationale and conditions for the requirement of chiral bioanalytical methods in bioequivalence studies. Eur. J. Clin. Pharmacol. 66 (6), 599–604 (2010).
   PubMed Web of Science ®Google Scholar
• MHRA . GMP Data Integrity Definitions and Guidance for Industry (2015). http://academy.gmp-compliance.org/guidemgr/files/Data_integrity_definitions_and_guidance_v2.pdf.
   Google Scholar
• MHRA . GxP Data Integrity Definitions and Guidance for Industry. Draft version for consultation (2016). http://academy.gmp-compliance.org/guidemgr/files/MHRA_GxP_data_integrity_consultation.pdf.
   Google Scholar
• Posa A , BräuerL, SchichtMet al. Schirmer strip vs. capillary tube method: non-invasive methods of obtaining proteins from tear fluid. Ann. Anat. 195, 137–142 (2013).
   PubMed Web of Science ®Google Scholar